Position in FOLD
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$57,638,397
+$1,135,289 QoQ
Shares Held
3,986,058
+0.5% QoQ
Ownership
1.27%
of shares outstanding
% of Portfolio
0.61%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in FOLD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Magnetar Financial LLC holds $179,874,666 across 37 Biotechnology names. FOLD ranks #1 (32.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | FOLD |
AMICUS THERAPEUTICS, INC.
This page
|
3,986,058 | $57,638,397 | |
| 2 | ACLX |
Arcellx, Inc.
|
394,931 | $45,345,977 | |
| 3 | APLS |
Apellis Pharmaceuticals, Inc.
|
869,229 | $34,969,082 | |
| 4 | TERN |
Terns Pharmaceuticals, Inc.
|
281,614 | $14,846,689 | |
| 5 | DAWN |
Day One Biopharmaceuticals, Inc.
|
645,173 | $13,832,508 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
16,009 | $2,705,840 | |
| 7 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
3,811 | $1,994,943 | |
| 8 | AUPH |
Aurinia Pharmaceuticals Inc.
|
67,626 | $1,002,216 |
All Filings in FOLD
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $57,638,397 | 3,986,058 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $56,503,108 | 3,967,915 | Shares | Sole | 2026-02-17 | |
| 2025-03-31 | $403,046 | 49,393 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $189,464 | 20,113 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $235,782 | 22,077 | Shares | Sole | 2024-11-13 | |
| 2021-06-30 | $181,714 | 18,850 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $296,449 | 30,005 | Shares | Sole | 2021-05-14 | |
| No filing history on record for this holder in this stock. | ||||||